BellRock Brands Inc. (DXBRF)
BellRock Brands Inc. operates in the Drug Manufacturers - Specialty & Generic industry of the Healthcare sector, headquartered in Denver, CO, US. The stock last traded at $0.00, up 0.00% on the session, giving a market capitalisation of $53,153. On trailing twelve-month figures it carries a trailing P/E of -0.00, a net margin of -181.5%. Its beta of -7.98 implies it has historically moved less than the broad market.
BellRock Brands Inc. is an enterprise engaged in the development, commercialization, and distribution of cannabis-based products across the United States, Canada, and international markets. The company's extensive product line encompasses a variety of cannabis-infused offerings for adult use, including edibles, confections, beverages, and concentrates. It also provides a comprehensive range of topical solutions such as transdermal patches, lotions, creams, tinctures, and cosmetic serums, in addition to vape products and capsules. Beyond cannabis, BellRock Brands also supplies branded hemp-derived products catering to both human and animal consumers. Its impressive brand roster features prominent names like Mary's Medicinals, Mary's Nutritionals, Mary's Methods, Mary's Tails, Beezle, Dixie, Synergy, Mindset, Aceso, Therabis, Défoncé, and Rebel Coast. Prior to October 2020, the entity operated under the name Dixie Brands Inc. Its corporate headquarters are situated in Denver, Colorado. Since October 10, 2022, BellRock Brands Inc. has functioned as a subsidiary of West 4th Holdings, LLC.
BellRock Brands Inc. is most often compared with the following Healthcare names: